APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Contract Development and Manufacturing Organization

A pharmaceutical CDMO provides contracted drug-development and manufacturing services, including process development, analytical work and production of drug substances or finished dosage forms.

Compare research editions
View pricing & licenses

Selected research

Industry Research

Pharmaceutical Contract Development and Manufacturing Organization Industry Research Report 2026

1 January 2026134 pages

Choose your research edition.

Industry ResearchPharmaceutical Contract Development and Manufacturing Organization Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Contract Development and Manufacturing Organization Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Contract Development and Manufacturing Organization Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Contract Development and Manufacturing Organization Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Contract Development and Manufacturing Organization Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Pharmaceutical Contract Development and Manufacturing Organization market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Pharmaceutical Contract Development and Manufacturing Organization market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmaceutical Contract Development and Manufacturing Organization market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmaceutical Contract Development and Manufacturing Organization market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmaceutical Contract Development and Manufacturing Organization include Catalent, Recipharm, Jubilant Life Sciences, Patheon Inc., Boehringer Ingelheim, Pfizer Centreone, Aenova Group, Famar and Baxter Pharmaceutical Solutions, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Pharmaceutical Contract Development and Manufacturing Organization market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceutical Contract Development and Manufacturing Organization.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pharmaceutical Contract Development and Manufacturing Organization Market by Company

Catalent

Recipharm

Jubilant Life Sciences

Patheon Inc.

Boehringer Ingelheim

Pfizer Centreone

Aenova Group

Famar

Baxter Pharmaceutical Solutions

Lonza Group

Tesa Labtec

Tapemark

ARX LLC

Cambrex

Samsung Biologics

Fujifilm Diosynth Biotechnologies

WuXi Biologics

Center for Breakthrough Medicines (CBM)

Siegfried AG

Pharmaceutical Contract Development and Manufacturing Organization Segment by Type

API Development

Pharmaceutical Manufacturing

Pharmaceutical Contract Development and Manufacturing Organization Segment by Application

Large Enterprise

SME

Pharmaceutical Contract Development and Manufacturing Organization Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Contract Development and Manufacturing Organization market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Contract Development and Manufacturing Organization and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Contract Development and Manufacturing Organization.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Pharmaceutical Contract Development and Manufacturing Organization companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Type (2021-2026) Table 7. Global Pharmaceutical Contract Development and Manufacturing Organization Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Type (2027-2032) Table 9. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Application (2021-2026) Table 11. Global Pharmaceutical Contract Development and Manufacturing Organization Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Application (2027-2032) Table 13. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Region (2021-2026) Table 16. Global Pharmaceutical Contract Development and Manufacturing Organization Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Region (2027-2032) Table 18. Pharmaceutical Contract Development and Manufacturing Organization Industry Trends Table 19. Pharmaceutical Contract Development and Manufacturing Organization Industry Drivers Table 20. Pharmaceutical Contract Development and Manufacturing Organization Industry Opportunities and Challenges Table 21. Pharmaceutical Contract Development and Manufacturing Organization Market Restraints Table 22. Global Top Pharmaceutical Contract Development and Manufacturing Organization Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Players (2021-2026) Table 24. Global Pharmaceutical Contract Development and Manufacturing Organization Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Pharmaceutical Contract Development and Manufacturing Organization, Headquarters and Area Served Table 26. Global Pharmaceutical Contract Development and Manufacturing Organization Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Pharmaceutical Contract Development and Manufacturing Organization by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Pharmaceutical Contract Development and Manufacturing Organization Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Pharmaceutical Contract Development and Manufacturing Organization Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2027-2032) & (US$ Million) Table 45. Catalent Company Information Table 46. Catalent Business Overview Table 47. Catalent Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) & (US$ Million) Table 48. Catalent Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 49. Catalent Recent Developments Table 50. Recipharm Company Information Table 51. Recipharm Business Overview Table 52. Recipharm Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) & (US$ Million) Table 53. Recipharm Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 54. Recipharm Recent Developments Table 55. Jubilant Life Sciences Company Information Table 56. Jubilant Life Sciences Business Overview Table 57. Jubilant Life Sciences Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) & (US$ Million) Table 58. Jubilant Life Sciences Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 59. Jubilant Life Sciences Recent Developments Table 60. Patheon Inc. Company Information Table 61. Patheon Inc. Business Overview Table 62. Patheon Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) & (US$ Million) Table 63. Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 64. Patheon Inc. Recent Developments Table 65. Boehringer Ingelheim Company Information Table 66. Boehringer Ingelheim Business Overview Table 67. Boehringer Ingelheim Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) & (US$ Million) Table 68. Boehringer Ingelheim Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 69. Boehringer Ingelheim Recent Developments Table 70. Pfizer Centreone Company Information Table 71. Pfizer Centreone Business Overview Table 72. Pfizer Centreone Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) & (US$ Million) Table 73. Pfizer Centreone Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 74. Pfizer Centreone Recent Developments Table 75. Aenova Group Company Information Table 76. Aenova Group Business Overview Table 77. Aenova Group Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) & (US$ Million) Table 78. Aenova Group Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 79. Aenova Group Recent Developments Table 80. Famar Company Information Table 81. Famar Business Overview Table 82. Famar Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) & (US$ Million) Table 83. Famar Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 84. Famar Recent Developments Table 85. Baxter Pharmaceutical Solutions Company Information Table 86. Baxter Pharmaceutical Solutions Business Overview Table 87. Baxter Pharmaceutical Solutions Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) & (US$ Million) Table 88. Baxter Pharmaceutical Solutions Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 89. Baxter Pharmaceutical Solutions Recent Developments Table 90. Lonza Group Company Information Table 91. Lonza Group Business Overview Table 92. Lonza Group Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) & (US$ Million) Table 93. Lonza Group Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 94. Lonza Group Recent Developments Table 95. Tesa Labtec Company Information Table 96. Tesa Labtec Business Overview Table 97. Tesa Labtec Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) & (US$ Million) Table 98. Tesa Labtec Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 99. Tesa Labtec Recent Developments Table 100. Tapemark Company Information Table 101. Tapemark Business Overview Table 102. Tapemark Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) & (US$ Million) Table 103. Tapemark Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 104. Tapemark Recent Developments Table 105. ARX LLC Company Information Table 106. ARX LLC Business Overview Table 107. ARX LLC Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) & (US$ Million) Table 108. ARX LLC Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 109. ARX LLC Recent Developments Table 110. Cambrex Company Information Table 111. Cambrex Business Overview Table 112. Cambrex Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) & (US$ Million) Table 113. Cambrex Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 114. Cambrex Recent Developments Table 115. Samsung Biologics Company Information Table 116. Samsung Biologics Business Overview Table 117. Samsung Biologics Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) & (US$ Million) Table 118. Samsung Biologics Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 119. Samsung Biologics Recent Developments Table 120. Fujifilm Diosynth Biotechnologies Company Information Table 121. Fujifilm Diosynth Biotechnologies Business Overview Table 122. Fujifilm Diosynth Biotechnologies Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) & (US$ Million) Table 123. Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 124. Fujifilm Diosynth Biotechnologies Recent Developments Table 125. WuXi Biologics Company Information Table 126. WuXi Biologics Business Overview Table 127. WuXi Biologics Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) & (US$ Million) Table 128. WuXi Biologics Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 129. WuXi Biologics Recent Developments Table 130. Center for Breakthrough Medicines (CBM) Company Information Table 131. Center for Breakthrough Medicines (CBM) Business Overview Table 132. Center for Breakthrough Medicines (CBM) Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) & (US$ Million) Table 133. Center for Breakthrough Medicines (CBM) Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 134. Center for Breakthrough Medicines (CBM) Recent Developments Table 135. Siegfried AG Company Information Table 136. Siegfried AG Business Overview Table 137. Siegfried AG Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) & (US$ Million) Table 138. Siegfried AG Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 139. Siegfried AG Recent Developments Table 140. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pharmaceutical Contract Development and Manufacturing Organization Product Image Figure 5. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Type: 2025 VS 2032 Figure 7. API Development Product Figure 8. Pharmaceutical Manufacturing Product Figure 9. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Application: 2025 VS 2032 Figure 11. Large Enterprise Product Figure 12. SME Product Figure 13. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 14. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Region: 2025 VS 2032 Figure 16. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Players in 2025 Figure 17. Global Pharmaceutical Contract Development and Manufacturing Organization Manufacturers Established Date Figure 18. Global Top 5 and 10 Pharmaceutical Contract Development and Manufacturing Organization Players Market Share by Revenue in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. North America Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 21. North America Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country (2021-2032) Figure 22. United States Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 23. Canada Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Mexico Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country (2021-2032) Figure 25. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country (2021-2032) Figure 27. Germany Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. France Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. U.K. Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. Italy Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Spain Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Russia Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Netherlands Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Nordic Countries Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country (2021-2032) Figure 37. China Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Japan Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. South Korea Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. India Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. India Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country (2021-2032) Figure 42. Australia Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. China Taiwan Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. Southeast Asia Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. South America Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. South America Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country (2021-2032) Figure 47. Brazil Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. Argentina Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. Chile Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Colombia Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Peru Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Catalent Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) Figure 53. Recipharm Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) Figure 54. Jubilant Life Sciences Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) Figure 55. Patheon Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) Figure 56. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) Figure 57. Pfizer Centreone Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) Figure 58. Aenova Group Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) Figure 59. Famar Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) Figure 60. Baxter Pharmaceutical Solutions Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) Figure 61. Lonza Group Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) Figure 62. Tesa Labtec Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) Figure 63. Tapemark Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) Figure 64. ARX LLC Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) Figure 65. Cambrex Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) Figure 66. Samsung Biologics Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) Figure 67. Fujifilm Diosynth Biotechnologies Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) Figure 68. WuXi Biologics Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) Figure 69. Center for Breakthrough Medicines (CBM) Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026) Figure 70. Siegfried AG Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026)

Scope & coverage.

Types
  • API Development
  • Pharmaceutical Manufacturing
Applications
  • Large Enterprise
  • SME
Companies covered
  • Catalent
  • Recipharm
  • Jubilant Life Sciences
  • Patheon Inc.
  • Boehringer Ingelheim
  • Pfizer Centreone
  • Aenova Group
  • Famar
  • Baxter Pharmaceutical Solutions
  • Lonza Group
  • Tesa Labtec
  • Tapemark
  • ARX LLC
  • Cambrex
  • Samsung Biologics
  • Fujifilm Diosynth Biotechnologies
  • WuXi Biologics
  • Center for Breakthrough Medicines (CBM)
  • Siegfried AG

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Pharmaceutical Contract Development and Manufacturing Organization by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 API Development
  5. 2.2.3 Pharmaceutical Manufacturing
  6. 2.3 Pharmaceutical Contract Development and Manufacturing Organization by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Large Enterprise
  9. 2.3.3 SME
  10. 2.4 Assumptions and Limitations
3 Pharmaceutical Contract Development and Manufacturing Organization Breakdown Data by Type
  1. 3.1 Global Pharmaceutical Contract Development and Manufacturing Organization Historic Market Size by Type (2021-2026)
  2. 3.2 Global Pharmaceutical Contract Development and Manufacturing Organization Forecasted Market Size by Type (2027-2032)
4 Pharmaceutical Contract Development and Manufacturing Organization Breakdown Data by Application
  1. 4.1 Global Pharmaceutical Contract Development and Manufacturing Organization Historic Market Size by Application (2021-2026)
  2. 4.2 Global Pharmaceutical Contract Development and Manufacturing Organization Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Pharmaceutical Contract Development and Manufacturing Organization Market Perspective (2021-2032)
  2. 5.2 Global Pharmaceutical Contract Development and Manufacturing Organization Growth Trends by Region
  3. 5.2.1 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Pharmaceutical Contract Development and Manufacturing Organization Historic Market Size by Region (2021-2026)
  5. 5.2.3 Pharmaceutical Contract Development and Manufacturing Organization Forecasted Market Size by Region (2027-2032)
  6. 5.3 Pharmaceutical Contract Development and Manufacturing Organization Market Dynamics
  7. 5.3.1 Pharmaceutical Contract Development and Manufacturing Organization Industry Trends
  8. 5.3.2 Pharmaceutical Contract Development and Manufacturing Organization Market Drivers
  9. 5.3.3 Pharmaceutical Contract Development and Manufacturing Organization Market Challenges
  10. 5.3.4 Pharmaceutical Contract Development and Manufacturing Organization Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Pharmaceutical Contract Development and Manufacturing Organization Players by Revenue
  2. 6.1.1 Global Top Pharmaceutical Contract Development and Manufacturing Organization Players by Revenue (2021-2026)
  3. 6.1.2 Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Pharmaceutical Contract Development and Manufacturing Organization Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Pharmaceutical Contract Development and Manufacturing Organization Head Office and Area Served
  6. 6.4 Global Pharmaceutical Contract Development and Manufacturing Organization Players, Product Type & Application
  7. 6.5 Global Pharmaceutical Contract Development and Manufacturing Organization Manufacturers Established Date
  8. 6.6 Global Pharmaceutical Contract Development and Manufacturing Organization Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Pharmaceutical Contract Development and Manufacturing Organization Market Size (2021-2032)
  2. 7.2 North America Pharmaceutical Contract Development and Manufacturing Organization Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2021-2026)
  4. 7.4 North America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size (2021-2032)
  2. 8.2 Europe Pharmaceutical Contract Development and Manufacturing Organization Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2021-2026)
  4. 8.4 Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size (2021-2032)
  2. 9.2 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Pharmaceutical Contract Development and Manufacturing Organization Market Size (2021-2032)
  2. 10.2 South America Pharmaceutical Contract Development and Manufacturing Organization Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2021-2026)
  4. 10.4 South America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size (2021-2032)
  2. 11.2 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Catalent
  2. 12.1.1 Catalent Company Information
  3. 12.1.2 Catalent Business Overview
  4. 12.1.3 Catalent Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026)
  5. 12.1.4 Catalent Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  6. 12.1.5 Catalent Recent Developments
  7. 12.2 Recipharm
  8. 12.2.1 Recipharm Company Information
  9. 12.2.2 Recipharm Business Overview
  10. 12.2.3 Recipharm Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026)
  11. 12.2.4 Recipharm Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  12. 12.2.5 Recipharm Recent Developments
  13. 12.3 Jubilant Life Sciences
  14. 12.3.1 Jubilant Life Sciences Company Information
  15. 12.3.2 Jubilant Life Sciences Business Overview
  16. 12.3.3 Jubilant Life Sciences Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026)
  17. 12.3.4 Jubilant Life Sciences Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  18. 12.3.5 Jubilant Life Sciences Recent Developments
  19. 12.4 Patheon Inc.
  20. 12.4.1 Patheon Inc. Company Information
  21. 12.4.2 Patheon Inc. Business Overview
  22. 12.4.3 Patheon Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026)
  23. 12.4.4 Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  24. 12.4.5 Patheon Inc. Recent Developments
  25. 12.5 Boehringer Ingelheim
  26. 12.5.1 Boehringer Ingelheim Company Information
  27. 12.5.2 Boehringer Ingelheim Business Overview
  28. 12.5.3 Boehringer Ingelheim Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026)
  29. 12.5.4 Boehringer Ingelheim Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  30. 12.5.5 Boehringer Ingelheim Recent Developments
  31. 12.6 Pfizer Centreone
  32. 12.6.1 Pfizer Centreone Company Information
  33. 12.6.2 Pfizer Centreone Business Overview
  34. 12.6.3 Pfizer Centreone Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026)
  35. 12.6.4 Pfizer Centreone Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  36. 12.6.5 Pfizer Centreone Recent Developments
  37. 12.7 Aenova Group
  38. 12.7.1 Aenova Group Company Information
  39. 12.7.2 Aenova Group Business Overview
  40. 12.7.3 Aenova Group Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026)
  41. 12.7.4 Aenova Group Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  42. 12.7.5 Aenova Group Recent Developments
  43. 12.8 Famar
  44. 12.8.1 Famar Company Information
  45. 12.8.2 Famar Business Overview
  46. 12.8.3 Famar Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026)
  47. 12.8.4 Famar Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  48. 12.8.5 Famar Recent Developments
  49. 12.9 Baxter Pharmaceutical Solutions
  50. 12.9.1 Baxter Pharmaceutical Solutions Company Information
  51. 12.9.2 Baxter Pharmaceutical Solutions Business Overview
  52. 12.9.3 Baxter Pharmaceutical Solutions Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026)
  53. 12.9.4 Baxter Pharmaceutical Solutions Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  54. 12.9.5 Baxter Pharmaceutical Solutions Recent Developments
  55. 12.10 Lonza Group
  56. 12.10.1 Lonza Group Company Information
  57. 12.10.2 Lonza Group Business Overview
  58. 12.10.3 Lonza Group Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026)
  59. 12.10.4 Lonza Group Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  60. 12.10.5 Lonza Group Recent Developments
  61. 12.11 Tesa Labtec
  62. 12.11.1 Tesa Labtec Company Information
  63. 12.11.2 Tesa Labtec Business Overview
  64. 12.11.3 Tesa Labtec Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026)
  65. 12.11.4 Tesa Labtec Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  66. 12.11.5 Tesa Labtec Recent Developments
  67. 12.12 Tapemark
  68. 12.12.1 Tapemark Company Information
  69. 12.12.2 Tapemark Business Overview
  70. 12.12.3 Tapemark Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026)
  71. 12.12.4 Tapemark Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  72. 12.12.5 Tapemark Recent Developments
  73. 12.13 ARX LLC
  74. 12.13.1 ARX LLC Company Information
  75. 12.13.2 ARX LLC Business Overview
  76. 12.13.3 ARX LLC Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026)
  77. 12.13.4 ARX LLC Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  78. 12.13.5 ARX LLC Recent Developments
  79. 12.14 Cambrex
  80. 12.14.1 Cambrex Company Information
  81. 12.14.2 Cambrex Business Overview
  82. 12.14.3 Cambrex Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026)
  83. 12.14.4 Cambrex Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  84. 12.14.5 Cambrex Recent Developments
  85. 12.15 Samsung Biologics
  86. 12.15.1 Samsung Biologics Company Information
  87. 12.15.2 Samsung Biologics Business Overview
  88. 12.15.3 Samsung Biologics Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026)
  89. 12.15.4 Samsung Biologics Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  90. 12.15.5 Samsung Biologics Recent Developments
  91. 12.16 Fujifilm Diosynth Biotechnologies
  92. 12.16.1 Fujifilm Diosynth Biotechnologies Company Information
  93. 12.16.2 Fujifilm Diosynth Biotechnologies Business Overview
  94. 12.16.3 Fujifilm Diosynth Biotechnologies Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026)
  95. 12.16.4 Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  96. 12.16.5 Fujifilm Diosynth Biotechnologies Recent Developments
  97. 12.17 WuXi Biologics
  98. 12.17.1 WuXi Biologics Company Information
  99. 12.17.2 WuXi Biologics Business Overview
  100. 12.17.3 WuXi Biologics Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026)
  101. 12.17.4 WuXi Biologics Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  102. 12.17.5 WuXi Biologics Recent Developments
  103. 12.18 Center for Breakthrough Medicines (CBM)
  104. 12.18.1 Center for Breakthrough Medicines (CBM) Company Information
  105. 12.18.2 Center for Breakthrough Medicines (CBM) Business Overview
  106. 12.18.3 Center for Breakthrough Medicines (CBM) Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026)
  107. 12.18.4 Center for Breakthrough Medicines (CBM) Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  108. 12.18.5 Center for Breakthrough Medicines (CBM) Recent Developments
  109. 12.19 Siegfried AG
  110. 12.19.1 Siegfried AG Company Information
  111. 12.19.2 Siegfried AG Business Overview
  112. 12.19.3 Siegfried AG Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2021-2026)
  113. 12.19.4 Siegfried AG Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  114. 12.19.5 Siegfried AG Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst